Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loxoprofen sodium eye drops for postoperative inflammation and pain after cataract surgery
CTR20241022Phase 3Completed
- Sponsor
- Guangzhou Aobo Pharmaceutical Technology
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loxoprofen in Postoperative ocular inflammation, post-operative ocular pain, sponsored by Guangzhou Aobo Pharmaceutical Technology. Started Apr 2024; status: completed.
02
Drugs
loxoprofen
03
Conditions
Postoperative ocular inflammationpost-operative ocular pain
Beyond the preview
Go deeper on CTR20241022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241022.